Literature DB >> 11740868

EGF and beta1 integrin convergently regulate migration of A431 carcinoma cell through MAP kinase activation.

E Kawahara1, Natsuko Nakada, Tetsuro Hikichi, Jun Kobayashi, Isao Nakanishi.   

Abstract

We found that the convergently epidermal growth factor (EGF)-induced signal and the collagen-induced signal activate mitogen-activated protein kinase (MAPK), which induces migration. We examined the signaling mechanisms of EGF-induced cell migration on collagen using the A431 carcinoma cell. EGF (10 ng/ml) induced migration on collagen, but inhibited proliferation. Using a MAPK cascade inhibitor, PD98059, it was shown that EGF-induced migration on collagen was mediated by MAPK whereas EGF-induced migration on fibronectin and vitronectin was not. PD98059 also showed that activation of MAPK induced by EGF enhanced the adhesiveness of A431 cells to collagen. By Western blotting analysis, the kinetics of MAPK phosphorylation induced by EGF and collagen was examined separately, and convergently. First of all, EGF without collagen caused transient MAPK phosphorylation. Collagen without EGF caused MAPK to be immediately and transiently dephosphorylated, and rephosphorylated followed by sustained hyperphosphorylation. EGF together with collagen caused an immediate, and sustained, hyperphosphorylation. These facts suggest that the transient MAPK dephosphorylation induced by collagen is required for migration in order to maintain an appropriate level of sustained phosphorylation. Furthermore, we found that adhesion of A431 cells to collagen was blocked by the anti-beta1 integrin antibody or by the mixed antibodies composed of anti-alpha1, -alpha2, and -alpha3 antibodies, indicating that collagen-induced MAPK phosphorylation was mediated through alpha1beta1, alpha2beta1, and alpha3beta1 integrins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11740868     DOI: 10.1006/excr.2001.5399

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.

Authors:  Caren V Lund; Mikhail Popkov; Laurent Magnenat; Carlos F Barbas
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

2.  Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli.

Authors:  Bianca Sparatore; Mauro Patrone; Mario Passalacqua; Marco Pedrazzi; Sabina Ledda; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

3.  Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells.

Authors:  Sittichai Koontongkaew; Panomwat Amornphimoltham; Paopanga Monthanpisut; Theeranuch Saensuk; Montira Leelakriangsak
Journal:  Med Oncol       Date:  2011-03-06       Impact factor: 3.064

4.  Dynamic regulation of extracellular signal-regulated kinase (ERK) by protein phosphatase 2A regulatory subunit B56γ1 in nuclei induces cell migration.

Authors:  Ei Kawahara; Shiori Maenaka; Eri Shimada; Yoshihiro Nishimura; Hiroshi Sakurai
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

5.  Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models.

Authors:  Ken Ito; Taro Semba; Toshimitsu Uenaka; Toshiaki Wakabayashi; Makoto Asada; Yasuhiro Funahashi
Journal:  Cancer Sci       Date:  2014-08       Impact factor: 6.716

6.  Klotho inhibits EGF-induced cell migration in Caki-1 cells through inactivation of EGFR and p38 MAPK signaling pathways.

Authors:  Mehdi Dehghani; Reynolds K Brobey; Yue Wang; Glauco Souza; Robert J Amato; Kevin P Rosenblatt
Journal:  Oncotarget       Date:  2018-06-01

7.  A Novel Marine Natural Product Derived Pyrroloiminoquinone with Potent Activity against Skin Cancer Cells.

Authors:  Jaden Cowan; Mohammad Shadab; Dwayaja H Nadkarni; Kailash Kc; Sadanandan E Velu; Nabiha Yusuf
Journal:  Mar Drugs       Date:  2019-07-27       Impact factor: 6.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.